1) Bambauer R, Schwarze U, Schiel R:Cyclosporin A and therapeutic plasma exchange in the treatments of severe systemic lupus erythematosus. Artif Organs 2000;24:852-6 2) Canas C, Tobon GJ, Granados M, Fernandez L:Diffuse alveolar hemorrhage in Colombian patients with systemic lupus erythematosus. Clin Rheumatol 2007;26:1947-9 3) Claridge S, Das P, Dorling A, Robson MG:Plasmapheresis as rescue therapy for systemic lupus erythematosus-associated diffuse alveolar hemorrhage. BMJ Case Rep 2011;2011:pii:bcr0220113893;doi:10.1136/bcr.02.2011.3893. erratum in:BMJ case Rep 2012;2012. doi:10.1136/bcr.02.2011.3893. corrl. Robson, Michael[corrected to Robson, Michael G] 4) Danieli MG, Palmieri C, Salvi A, et al:Synchronized therapy and high-dose cyclophosphamide in proliferative lupus nephritis. J Clin Apher 2002;17:72-7 5) Gaubitz M, Schneider KM:Immunoadsorption in systemic lupus erythematosus:different techniques and their current role in medical therapy. Ther Apher Dial 2003;7:183-8 6) Gaubitz M, Seidel M, Kummer S, et al:Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus. J Autoimmun 1998;11:495-501 7) Hanly JG, Hong C, Zayed E, et al:Immunomodulating effects of synchronized plasmapheresis and intravenous bolus cyclophosphamide in systemic lupus erythematosus. Lupus 1995;4:457-63 8) Sorensen H, Schneidewind-Mueller JM, Lange D, et al:Pilot clinical study of Adacolumn cytapheresis in patients with systemic lupus erythematosus. Rheumatol Int 2006;26:409-15 9) Hershko AY, Sceinman-Elazari A, Amar S, Naparstek Y:Extracorporeal immunoadsorption of antibodies against the VRT-101 laminin epitope in systemic lupus erythematosus:a feasibility evaluation study. Immunol Res 2013;56:376-81 10) Kronbichler A, Brezina B, Quintana LF, Jayne DR:Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome:a systemic review. Autoimmun Rev 2016;15:38-49 11) Lewis EJ, Hunsicker LG, lan SP, et al:A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med 1992;326:1373-9 12) Loo CY, Said M, Mohd R, et al:Immunoadsorption and plasmapheresis are equally efficatious as adjunctive therapies for severe lupus nephritis. Transfus Apher Sci 2010;43:335-40 13) Marmont du Haut Champ AM:Hematopoietic stem cell transplantation for systemic lupus erythematosus. Clin Dev Immunol 2012;2012:380391 14) Neuwelt CM:The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus:different techniques and their current role in medical therapy. Ther Apher Dial 2003;7:173-82 15) Richter HI, Krumann J, Gorez G:Extracorporeal photopheresis in therapy-refractory disseminated discoid lupus erythematosus. Hautarzt 1998;49:487-91 16) Schroeder JO, Euler HH:Treatment combining plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus. Adv Exp Med Biol 1989;260:203-13 17) Stummvoll GH, Schmaldienst S, Smolen JS, et al:Lupus nephritis:prolonged immunoadsorption(IAS)reduces proteinuria and stabilizes global disease activity. Nephrol Dial Transplant 2012;27:618-26 18) Wallace DJ, Goldfinger D, Pepkowitz SH, et al:Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritis. J Clin Apher 1998;13:163-6 19) Wei N, Klippel JH, Huston DP, et al:Randomized trial of plasma exchange in mild systemic lupus erythematosus. Lancet 1983;1:17-22 20) Li M-X, Wang Y-D, Qiu Q, et al:Therapeutic effect of double-filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis. J Clin Apher 2016;31:375-80